CTXR
Citius Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.59
−2.38%Margins
Gross margin
20.0%
EBITDA margin
-804.6%
EBIT margin
-863.9%
Net margin
-651.3%
FCF margin
-490.7%
-69.5%
Return on equity
-32.5%
Return on assets
-83.2%
Return on invested capital
0.05x
Asset turnover
-$34.9M
Cash from operations
$0.62
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026